Safety and Tolerability of Opicapone in Patients with Parkinson’s Disease and Motor Fluctuations: Pooled Analysis of Two Double-Blind, Placebo-Controlled Phase 3 Studies

Need to get in touch with us?

medinfo@neurocrine.com 1-877-641-3461